PARP1 and PARP7 safeguard the lineage-specificity and pluripotency of ES cells

PARP1 and PARP7 safeguard the lineage-specificity and pluripotency of ES cells

Bibliographic Details
Main Author:	Roper, Stephen James
Published:	University of Cambridge 2011
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.609467

Similar Items

Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies
by: José Yélamos, et al.
Published: (2020-02-01)

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
by: Lotte van Beek, et al.
Published: (2021-05-01)

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
by: Luyao Wang, et al.
Published: (2017-10-01)

Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells
by: Paulina Gil-Kulik, et al.
Published: (2020-05-01)

Molecular Mechanisms of PARP-1 Inhibitor 7-Methylguanine
by: Dmitry Nilov, et al.
Published: (2020-03-01)

Functional Roles of PARP7 Oral Cancer Cells
by: Pei-Yu Lin, et al.
Published: (2008)

Serine-linked PARP1 auto-modification controls PARP inhibitor response
by: Evgeniia Prokhorova, et al.
Published: (2021-07-01)

Differential regulation of breast cancer bone metastasis by PARP1 and PARP2
by: Hao Zuo, et al.
Published: (2020-03-01)

Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing's Sarcoma.
by: Sonja J Gill, et al.
Published: (2015-01-01)

Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry
by: Isabelle Maxim, et al.
Published: (2010-04-01)

Design, Synthesis and Molecular Modeling Study of Conjugates of ADP and Morpholino Nucleosides as A Novel Class of Inhibitors of PARP-1, PARP-2 and PARP-3
by: Yuliya V. Sherstyuk, et al.
Published: (2019-12-01)

The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency
by: Marco Gatti, et al.
Published: (2020-08-01)

Revealing the selective mechanisms of inhibitors to PARP-1 and PARP-2 via multiple computational methods
by: Hongye Hu, et al.
Published: (2020-05-01)

The HSF1–PARP13–PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis
by: Mitsuaki Fujimoto, et al.
Published: (2017-11-01)

The Role of PARP1 in Monocyte and Macrophage Commitment and Specification: Future Perspectives and Limitations for the Treatment of Monocyte and Macrophage Relevant Diseases with PARP Inhibitors
by: Maciej Sobczak, et al.
Published: (2020-09-01)

ADP-ribosyltransferase PARP11 suppresses Zika virus in synergy with PARP12
by: Lili Li, et al.
Published: (2021-06-01)

The Nucleolus and PARP1 in Cancer Biology
by: Marina Engbrecht, et al.
Published: (2020-07-01)

PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response
by: Chiho Kim, et al.
Published: (2020-08-01)

PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models
by: Ymera Pignochino, et al.
Published: (2017-04-01)

Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade.
by: Fenqing Shang, et al.
Published: (2016-01-01)

Investigation of the Complexes Formed between PARP1 Inhibitors and PARP1 G-Quadruplex at the Gene Promoter Region
by: Sabrina Dallavalle, et al.
Published: (2021-08-01)

PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation
by: Hiroshi Iwata, et al.
Published: (2016-10-01)

ADP ribosylation by PARP-1 suppresses HOXB7 transcriptional activity.
by: Xinyan Wu, et al.
Published: (2012-01-01)

New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage
by: Zongying Gu, et al.
Published: (2019-08-01)

Molecular Mechanism of Selective Binding of NMS-P118 to PARP-1 and PARP-2: A Computational Perspective
by: Ran Wang, et al.
Published: (2020-04-01)

The contribution of PARP1, PARP2 and poly(ADP-ribosyl)ation to base excision repair in the nucleosomal context
by: M. M. Kutuzov, et al.
Published: (2021-03-01)

Dual Inhibitors of PARPs and ROCKs
by: Albert A. Antolín, et al.
Published: (2018-10-01)

Advances and perspectives of PARP inhibitors
by: Ming Yi, et al.
Published: (2019-11-01)

Mitochondrial Protection by PARP Inhibition
by: Ferenc Gallyas Jr, et al.
Published: (2020-04-01)

PARP14 in allergic inflammation
by: Krishnamurthy, Purna
Published: (2017)

The PARP Way to Epigenetic Changes
by: Simone Ummarino, et al.
Published: (2021-03-01)

Virtual screening for plant PARP inhibitors – what can be learned from human PARP inhibitors?
by: Heym Peter-Paul, et al.
Published: (2012-05-01)

Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
by: Hyoung Kim, et al.
Published: (2020-07-01)

PARP-1 protein expression in glioblastoma multiforme
by: A. Galia, et al.
Published: (2012-02-01)

The Multifactorial Role of PARP-1 in Tumor Microenvironment
by: Juan Manuel Martí, et al.
Published: (2020-03-01)

PARP/XRCC1 surveillance of the human genome
by: Gittens, William
Published: (2018)

Calcium Modulation of PARP-mediated Cell Death
by: Muñoz, Frances M.
Published: (2015)

Deacetylation-dependent regulation of PARP1 by SIRT2 dictates ubiquitination of PARP1 in oxidative stress-induced vascular injury
by: Naijin Zhang, et al.
Published: (2021-11-01)

Transgelin interacts with PARP1 in human colon cancer cells
by: Zhen-xian Lew, et al.
Published: (2020-08-01)

Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance
by: Stephen J. Pettitt, et al.
Published: (2018-05-01)